Case Study: Cancer Care Northwest achieves 11x higher germline genetic testing rates with CancerIQ

Cancer Care Northwest achieves 78.3% germline testing rate with CancerIQ

Cancer Care Northwest (CCNW) faced the common oncology challenge of effectively implementing germline genetic testing, struggling to identify eligible patients and ensure they completed testing through a traditional referral process. To address this, they partnered with the vendor CancerIQ.

By utilizing CancerIQ's digital workflows and access to genetics expertise, CCNW replaced its referral model with a point-of-care testing approach. This solution equipped their specialists and advanced practice providers to deliver testing confidently. As a result, CancerIQ helped CCNW achieve a germline testing rate of 78.3%, which is more than 11 times the national average.

Cancer Care Northwest (ccnw)